 |
인쇄하기
취소
|
Reductil generic makers to face tougher license procedure
A number of Korean generic makers to develop the generic version of Reductil capsule (sibutramine hydrochloride) will have to pass through more complicated procedures for the approval of their salt-modified compounds.
In a Q/A session on January 22, the Korea Food and Drug Administration said that any salt-modified compounds of Reductil cannot be approved even under the provisional condition...
In a Q/A session on January 22, the Korea Food and Drug Administration said that any salt-modified compounds of Reductil cannot be approved even under the provisional condition...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.